Moderna Inc. ($MRNA) Stock Forecast: Down 5.1% Today

What is Moderna Inc.?

Moderna Inc. (MRNA) is a biotechnology company recognized for its mRNA-based vaccines, including the popular COVID-19 vaccine. The stock is publicly traded on the NASDAQ exchange.

Why is Moderna Inc. going down?

MRNA stock is down 5.1% on Nov 4, 2025 18:42

• MRNA stock faced a bearish trajectory attributed to various factors:
• Declining demand for the COVID-19 vaccine affecting the company's earnings forecast.
• Recent setbacks in clinical trials overshadowing positive pipeline updates and causing unease among investors.
• Despite prior stock price surges, the trend in earnings estimate revisions may not support further upward momentum.
• Reduced short interest suggesting potential waning market backing, contributing to the stock's downward pressure.

MRNA Price Chart

MRNA Technical Analysis

MRNA News

Should You Buy Moderna Stock Ahead of Q3 Earnings Report?

MRNA is likely to have faced earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand weighs on its outlook.

https://www.zacks.com/stock/news/2784347/should-you-buy-moderna-stock-ahead-of-q3-earnings-report

Moderna Stock Is Sliding Monday: What's Going On? - Moderna ( NASDAQ:MRNA )

Moderna Inc ( NASDAQ:MRNA ) stock is trading sharply lower on Monday afternoon as recent clinical setbacks overshadowed positive pipeline news. MRNA stock is struggling to find support. Check out the latest moves here.

https://www.benzinga.com/trading-ideas/movers/25/11/48605214/moderna-stock-is-sliding-monday-whats-going-on

Moderna ( MRNA ) Stock Is Trading Lower Friday: What's Going On? - Moderna ( NASDAQ:MRNA )

Moderna Inc ( NASDAQ:MRNA ) shares are trading lower on Friday afternoon, giving back a portion of the gains seen on Thursday. Here's what investors need to know.

https://www.benzinga.com/trading-ideas/movers/25/10/48573256/moderna-mrna-stock-is-trading-lower-friday-whats-going-on

Strength Seen in Moderna ( MRNA ) : Can Its 13.9% Jump Turn into More Strength?

Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

https://www.zacks.com/stock/news/2782334/strength-seen-in-moderna-mrna-can-its-139-jump-turn-into-more-strength

Is Moderna Inc Gaining or Losing Market Support? - Moderna ( NASDAQ:MRNA )

Moderna Inc's ( NYSE:MRNA ) short interest as a percent of float has fallen 12.38% since its last report. According to exchange reported data, there are now 65.04 million shares sold short, which is 20.25% of all regular shares that are available for trading.

https://www.benzinga.com/insights/short-sellers/25/10/48534419/is-moderna-inc-gaining-or-losing-market-support

Trending Today

ZCash ($ZEC) Crypto Forecast: Down 13.5% Today

Ethereum ($ETH) Crypto Forecast: Up 5.1% Today

Binance Coin ($BNB) Crypto Forecast: Up 5.4% Today

Moderna Inc. Price History

03.10.2025 - MRNA Stock was down 5.8%

• Moderna (MRNA) stock saw a downward trend today, which could be linked to profit-taking following recent gains.
• A decline in short interest suggests a potential loss of market backing, potentially contributing to the stock's decline.
• Worries about the upcoming Q3 earnings drop may have impacted investor confidence and fueled the bearish movement.
• Despite recent fluctuations, Moderna's long-term outlook and innovative mRNA technology show promise, positioning it as a stock worth monitoring for future developments.

04.10.2025 - MRNA Stock was down 5.1%

• MRNA stock faced a bearish trajectory attributed to various factors:
• Declining demand for the COVID-19 vaccine affecting the company's earnings forecast.
• Recent setbacks in clinical trials overshadowing positive pipeline updates and causing unease among investors.
• Despite prior stock price surges, the trend in earnings estimate revisions may not support further upward momentum.
• Reduced short interest suggesting potential waning market backing, contributing to the stock's downward pressure.

04.10.2025 - MRNA Stock was down 5.1%

• MRNA stock experienced a bearish movement likely due to:
• Earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand impacts its outlook.
• Recent clinical setbacks overshadowing positive pipeline news, causing investor concern.
• Market sentiment shifting as short interest in MRNA shares decreases, indicating potential loss of market support.
• The combination of these factors contributed to the strong bearish movement in MRNA stock as investors reevaluate the company's growth prospects amidst evolving market conditions.

08.09.2025 - MRNA Stock was up 6.1%

• Moderna's stock price surged by +2.83% following positive sentiment in the pharmaceutical sector and a general uptrend in the market.
• The anticipation of up to 10 new product launches over the next four years has likely boosted investor confidence, signaling a potential diversification away from reliance on COVID-19 vaccine sales.
• Breaking above the 50-day moving average is seen as a bullish signal, indicating potential further upside for the stock.
• The overall market optimism, coupled with Moderna's strategic moves towards product diversification, has contributed to the bullish movement in MRNA stock today.

09.09.2025 - MRNA Stock was down 5.6%

• Despite recent developments, Moderna's stock experienced a bearish movement today.
• The discrepancy between noteworthy developments and the stock's movement could be attributed to profit-taking by investors.
• Market sentiment or broader economic factors may have affected Moderna's stock performance, overshadowing recent positive news.
• Investors should consider both company-specific updates and market conditions when trading Moderna's stock.

31.09.2025 - MRNA Stock was up 12.4%

• Moderna (MRNA) saw a robust upward movement, with a notable 13.9% increase in its stock price.
• A 12.38% decline in short interest hints at growing market support and favorable sentiment towards the company.
• Despite predictions of a Q3 earnings decrease, Moderna's stock outperformed the broader market, indicating investor confidence in its future growth.
• The recent trend in earnings estimate revisions may not sustain the stock's current upward trajectory, signaling potential volatility ahead.

30.09.2025 - MRNA Stock was up 8.0%

• Despite expectations of a decline in Q3 earnings, Moderna (MRNA) surprised the market with a strong bullish movement, outperforming the broader market.
• The bullish movement could be attributed to investor optimism surrounding the company's potential for future vaccine developments and revenue growth.
• The market may be reacting positively to Moderna's resilience and ability to navigate challenges, showcasing confidence in its long-term prospects.
• This unexpected bullish movement showcases how investor sentiment and market performance can sometimes diverge from analysts' expectations.

30.09.2025 - MRNA Stock was up 17.5%

• The decrease in short interest suggests a rising positive sentiment towards Moderna's stock.
• Despite anticipated Q3 earnings decline, Moderna outperformed the broader market, demonstrating resilience and investor confidence.
• The optimistic market movement may be due to excitement about the company's innovative mRNA technology and potential future developments in the healthcare sector.
• Investors appear to be placing more importance on Moderna's long-term growth potential rather than short-term earnings fluctuations, fueling the bullish trend in the stock.

28.09.2025 - MRNA Stock was down 5.1%

• Moderna's stock (MRNA) experienced a strong bearish movement today, closing at $26.85 with a -2.33% change from the previous day.
• The market reacted negatively to the news that Moderna halted its CMV vaccine program due to the vaccine falling short in preventing infection in a Phase 3 trial.
• Investors might be concerned about the company's future pipeline and potential setbacks in developing new vaccines.
• This news highlights the volatility and risks associated with biotech stocks, where clinical trial results can significantly impact stock performance.

15.09.2025 - MRNA Stock was up 5.3%

• Moderna's stock (MRNA) demonstrated strong bullish movement today, surpassing the market performance.
• Positive response rates for its skin cancer combo therapy and encouraging early data for its investigational cancer antigen therapy presented at the 2025 European Society for Medical Oncology Congress likely influenced the bullish trend.
• Investor optimism regarding Moderna's progress in cancer treatment is fueling the increase in stock price, with expectations of future growth in this sector.
• The company's track record of innovation and promising results in the oncology field is attracting investor attention and bolstering confidence in Moderna's long-term prospects, evident in the stock's upward trajectory.

01.09.2025 - MRNA Stock was up 8.2%

• Moderna stock surged today, likely driven by the positive sentiment in the pharmaceutical sector following a landmark agreement between another company and the Trump administration to lower prescription drug prices.
• Despite a recent dip in the stock price, the overall bullish movement today indicates that investors are optimistic about Moderna's future prospects and its role in the healthcare industry.
• The positive market response suggests that investors view Moderna as a key player in the development of innovative medical solutions, particularly in the context of the ongoing global health crisis.

14.09.2025 - MRNA Stock was down 5.7%

• Promising early data for Moderna's investigational cancer antigen therapy, mRNA-4359, was presented at a medical oncology congress, suggesting potential progress in cancer treatment.
• Despite advancements in cancer therapies, Moderna's stock saw a decline, possibly attributed to profit-taking following recent gains or shifts in market sentiment.
• The market's reaction to the data presentation may have been negative, with expectations for more immediate commercialization or revenue impact not being met, contributing to the stock's bearish movement.